Stay informed with the latest litigation news. Explore now

Eisai competitive analysis

Latest publications and patents of Eisai New

Explore the latest publications and patents granted to Eisai, showcasing their recent innovations and technological advancements.

Last updated on: Sep 3, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Eisai

Nov 29, 2023Tumor-Treating Pharmaceutical CompositionGranted And Under Opposition
Oct 25, 2023Method For Suppressing Bitterness Of Quinoline DerivativeGranted And Under Opposition
Aug 10, 2022High-Purity Quinoline Derivative And Method For Manufacturing SameGranted And Under Opposition
May 4, 2022Combination Of A Pd-1 Antagonist And Eribulin For Treating CancerRevoked
Jun 30, 2021Tumor Therapeutic AgentGranted And Under Opposition
Jan 24, 2018MicellesNo Opposition Filed Within Time Limit

Explore Eisai's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 29, 2023Tumor-Treating Pharmaceutical Composition1
Oct 25, 2023Method For Suppressing Bitterness Of Quinoline Derivative8
Aug 10, 2022High-Purity Quinoline Derivative And Method For Manufacturing Same9
May 4, 2022Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer4
Jun 30, 2021Tumor Therapeutic Agent1

Latest PTAB cases involving Eisai New

Discover the latest PTAB cases involving Eisai, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 9, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Eisai

PGR2021-00047Feb 3, 2021EISAICRYSTAL PHARMACEUTICAL SUZHOUFinal Written Decision

Top competitors of Eisai

Top competitors of Eisai based on patent oppositions.